GOLD2024

CANCER RESEARCH & TREATMENT FUND INC

aka CR&T   |   New York, NY   |  https://www.crt.org
GuideStar Charity Check

CANCER RESEARCH & TREATMENT FUND INC

EIN: 13-6272085


Mission

The mission of Cancer Research & Treatment Fund (CR&T) is to fund research that will lead to new therapies and cures for cancer, with a particular focus on blood cancer, especially the myelproliferative neoplasms (MPN). CR&T sponsored investigators have also contributed to advances in breast, lung, and prostate cancer. For more information, please visit www.crt.org.

Ruling year info

1968

President

Thomas M. Silver

Main address

500 E 77th St Ste 1001

New York, NY 10162 USA

Show more contact info

EIN

13-6272085

Subject area info

Cancers

Population served info

Chronically ill people

NTEE code info

Cancer Research (H30)

IRS subsection

501(c)(3) Public Charity

IRS filing requirement

This organization is required to file an IRS Form 990 or 990-EZ.

Tax forms

Communication

Programs and results

What we aim to solve

This profile needs more info.

If it is your nonprofit, add a problem overview.

Login and update

Our programs

SOURCE: Self-reported by organization

What are the organization's current programs, how do they measure success, and who do the programs serve?

Grantmaking

CR&T Provides resources for state-of-the-art research that leads to effective treatment of cancers, with a particular focus on blood cancers, including myeloproliferative neoplasms (MPN).

Population(s) Served
Chronically ill people

Where we work

Financials

CANCER RESEARCH & TREATMENT FUND INC
Fiscal year: Jan 01 - Dec 31
Financial documents
2022 2021 2020
done  Yes, financials were audited by an independent accountant. info

Revenue vs. expenses:  breakdown

SOURCE: IRS Form 990 info
NET GAIN/LOSS:    in 
Note: When component data are not available, the graph displays the total Revenue and/or Expense values.

Liquidity in 2022 info

SOURCE: IRS Form 990

1.93

Average of 24.40 over 10 years

Months of cash in 2022 info

SOURCE: IRS Form 990

8.4

Average of 12.1 over 10 years

Fringe rate in 2022 info

SOURCE: IRS Form 990

9%

Average of 11% over 10 years

Funding sources info

Source: IRS Form 990

Assets & liabilities info

Source: IRS Form 990

Financial data

SOURCE: IRS Form 990

CANCER RESEARCH & TREATMENT FUND INC

Revenue & expenses

Fiscal Year: Jan 01 - Dec 31

SOURCE: IRS Form 990 info

Fiscal year ending: cloud_download Download Data

CANCER RESEARCH & TREATMENT FUND INC

Balance sheet

Fiscal Year: Jan 01 - Dec 31

SOURCE: IRS Form 990 info

The balance sheet gives a snapshot of the financial health of an organization at a particular point in time. An organization's total assets should generally exceed its total liabilities, or it cannot survive long, but the types of assets and liabilities must also be considered. For instance, an organization's current assets (cash, receivables, securities, etc.) should be sufficient to cover its current liabilities (payables, deferred revenue, current year loan, and note payments). Otherwise, the organization may face solvency problems. On the other hand, an organization whose cash and equivalents greatly exceed its current liabilities might not be putting its money to best use.

Fiscal year ending: cloud_download Download Data

CANCER RESEARCH & TREATMENT FUND INC

Financial trends analysis Glossary & formula definitions

Fiscal Year: Jan 01 - Dec 31

SOURCE: IRS Form 990 info

This snapshot of CANCER RESEARCH & TREATMENT FUND INC’s financial trends applies Nonprofit Finance Fund® analysis to data hosted by GuideStar. While it highlights the data that matter most, remember that context is key – numbers only tell part of any story.

Created in partnership with

Business model indicators

Profitability info 2018 2019 2020 2021 2022
Unrestricted surplus (deficit) before depreciation -$892,173 $1,534,474 $1,376,145 $975,455 -$2,437,785
As % of expenses -78.4% 131.2% 170.7% 120.5% -254.9%
Unrestricted surplus (deficit) after depreciation -$892,173 $1,533,552 $1,373,378 $974,226 -$2,438,400
As % of expenses -78.4% 131.0% 169.8% 120.1% -254.8%
Revenue composition info
Total revenue (unrestricted & restricted) $1,593,864 $1,228,731 $1,420,266 $1,096,322 $573,018
Total revenue, % change over prior year 48.6% -22.9% 15.6% -22.8% -47.7%
Program services revenue 0.0% 0.0% 0.0% 0.0% 0.0%
Membership dues 0.0% 0.0% 0.0% 0.0% 0.0%
Investment income 5.7% 6.4% 8.7% 12.5% 12.5%
Government grants 0.0% 0.0% 0.0% 0.0% 0.0%
All other grants and contributions 45.3% 52.7% 48.5% 44.3% 83.8%
Other revenue 49.0% 40.9% 42.9% 43.2% 3.7%
Expense composition info
Total expenses before depreciation $1,137,755 $1,169,910 $806,108 $809,618 $956,510
Total expenses, % change over prior year -8.1% 2.8% -31.1% 0.4% 18.1%
Personnel 10.6% 11.0% 31.3% 33.3% 29.9%
Professional fees 2.7% 2.6% 4.8% 4.8% 4.8%
Occupancy 3.6% 3.5% 5.4% 5.3% 4.6%
Interest 0.0% 0.0% 0.0% 0.0% 0.0%
Pass-through 75.4% 75.5% 48.8% 47.2% 52.9%
All other expenses 7.7% 7.4% 9.7% 9.3% 7.8%
Full cost components (estimated) info 2018 2019 2020 2021 2022
Total expenses (after depreciation) $1,137,755 $1,170,832 $808,875 $810,847 $957,125
One month of savings $94,813 $97,493 $67,176 $67,468 $79,709
Debt principal payment $0 $0 $0 $0 $0
Fixed asset additions $0 $8,300 $0 $0 $0
Total full costs (estimated) $1,232,568 $1,276,625 $876,051 $878,315 $1,036,834

Capital structure indicators

Liquidity info 2018 2019 2020 2021 2022
Months of cash 11.9 9.8 38.4 14.2 8.4
Months of cash and investments 118.5 132.9 207.9 219.7 157.0
Months of estimated liquid unrestricted net assets 113.8 126.3 203.9 217.4 153.5
Balance sheet composition info 2018 2019 2020 2021 2022
Cash $1,132,670 $957,889 $2,578,222 $957,332 $668,774
Investments $10,102,091 $11,995,153 $11,386,420 $13,862,641 $11,845,986
Receivables $5,000 $0 $0 $24,270 $0
Gross land, buildings, equipment (LBE) $86,931 $95,231 $95,231 $95,231 $95,231
Accumulated depreciation (as a % of LBE) 100.0% 92.3% 95.2% 96.4% 97.1%
Liabilities (as a % of assets) 4.0% 5.0% 2.0% 1.3% 2.8%
Unrestricted net assets $10,791,677 $12,325,229 $13,698,607 $14,672,833 $12,234,433
Temporarily restricted net assets $13,447 N/A N/A N/A N/A
Permanently restricted net assets $0 N/A N/A N/A N/A
Total restricted net assets $13,447 $0 $0 $0 $0
Total net assets $10,805,124 $12,325,229 $13,698,607 $14,672,833 $12,234,433

Key data checks

Key data checks info 2018 2019 2020 2021 2022
Material data errors No No No No No

Operations

The people, governance practices, and partners that make the organization tick.

Documents
Letter of Determination is not available for this organization
Form 1023/1024 is not available for this organization

President

Thomas M. Silver

Number of employees

Source: IRS Form 990

CANCER RESEARCH & TREATMENT FUND INC

Officers, directors, trustees, and key employees

SOURCE: IRS Form 990

Compensation
Other
Related
Show data for fiscal year
Compensation data
Download up to 5 most recent years of officer and director compensation data for this organization

CANCER RESEARCH & TREATMENT FUND INC

Highest paid employees

SOURCE: IRS Form 990

Compensation
Other
Related
Show data for fiscal year
Compensation data
Download up to 5 most recent years of highest paid employee data for this organization

CANCER RESEARCH & TREATMENT FUND INC

Board of directors
as of 01/29/2024
SOURCE: Self-reported by organization
Board of directors data
Download the most recent year of board of directors data for this organization
Board chair

Mr. Tom Silver

Leadership Directories

Term: 2016 -

Organizational demographics

SOURCE: Self-reported; last updated 8/17/2022

Who works and leads organizations that serve our diverse communities? Candid partnered with CHANGE Philanthropy on this demographic section.

Leadership

The organization's leader identifies as:

Race & ethnicity
White/Caucasian/European
Gender identity
Male
Disability status
Decline to state

Race & ethnicity

No data

Gender identity

No data

Transgender Identity

No data

Sexual orientation

No data

Disability

No data

There are no contractors recorded for this organization.

Professional fundraisers

Fiscal year ending

SOURCE: IRS Form 990 Schedule G

Solicitation activities
Gross receipts from fundraising
Retained by organization
Paid to fundraiser